Second patent issued to building protection system

The U.S. Patent and Trademark Office recently issued a second patent on a toxin detection system created by Building Protection Systems, Inc., that is meant to protect buildings against toxins released in their air system.

BPSI’s Building Sentry One toxin detection system and its related products has received attention from Fortune 100 companies in the United States, as well as the Middle East, Great Britain and Asia.

Building Sentry One has operated for 110,000 hours without false positives and has also received a full Safety Act designation from the Department of Homeland Security for its detection of airborne chemical and radiological threats.

After detecting toxins in an air ventilation system and then identifying them, Building Sentry One, Metro Sentry One - designed for mass transit systems - and Alpha Sentry One - designed for smaller buildings - communicate their findings to an equipment control system.

The air ventilation system is then immediately shut down and BPSI’s Remote Monitoring Center is notified of a potential terrorist attack so that first responders can be dispatched to the scene.

"We are continuing to adapt the Sentry One solution to more high-value venues using our advanced next-generation detection technology,” Greg Eiler, BPSI's president, said. “The system not only saves lives, but benefits decision-makers by limiting their liability and providing a new standard for security, safety, and asset protection."